Relationship between Serum Resistin and Insulin Resistance among Obese Non-Diabetic Patients in a Nigerian Tertiary Hospital

Authors

  • F.M. Agbaraolorunpo
  • Ademola Lafenwa Department of Clinical Pathology, Lagos University Teaching Hospital, Lagos, Nigeria
  • Basil Bruno
  • E.C Azinge

DOI:

https://doi.org/10.54548/njps.v39i1.4

Keywords:

Obesity, resistin, insulin resistance, adiposity, Type 2 diabetes mellitus, Nigerians

Abstract

There is paucity of information on the relationship between resistin and cardiometabolic outcome among non-diabetic obese in Africa, especially Nigeria with a growing prevalence of obesity and cardiovascular events. This study aims to elucidate the relationship between serum resistin and insulin resistance among non-diabetic obese patients. This is a cross-sectional study, involving 100 non-diabetic obese and 100 non-obese Nigerians. Participants waist circumference, abdominal circumference and waist-hip ratio were measured alongside fasting blood glucose (FBG), lipid profile, remnant cholesterol and blood pressure. Serum resistin and insulin were determined with ELISA technique. Insulin resistance was assessed using the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) formula. Data was analyzed with Manny-Whitney test to compares the median of the observation between the two groups and chi-square for association test.  Although FBG, serum insulin level and HOMA-insulin resistance (p<0.001) were significantly higher in the obese group, ditto for total cholesterol, LDL and remnant cholesterol, blood pressure and myocardial oxygen demand (MOD). However, circulatory resistin level in  the obese group 1.63 (1.45-1.74)  was comparable with the non-obese groups  1.63(1.52-1.70), and there was no correlation between  resistin and insulin resistance and any anthropometrics indices Conclusion: Put together, resistin may not be a constant factor in the development of insulin resistance or obesity-related metabolic dysfunction in some obese subsets, hence the need to explore other potential adiponectin factors contributing to cardiometabolic outcomes in non-diabetic obese individuals in Nigeria

References

Adeloye, D., Ige-Elegbede, J. O., Ezejimofor, M., Owolabi, E. O., Ezeigwe, N., Omoyele, C., Mpazanje, R. G., Dewan, M. T., Agogo, E., Gadanya, M. A., Alemu, W., Harhay, M. O., Auta, A., & Adebiyi, A. O. (2021). Estimating the prevalence of overweight and obesity in Nigeria in 2020: A systematic review and meta-analysis. Annals of Medicine, 53(1), 495–507. https://doi.org/10.1080/07853890.2021.1897665

Al-Harithy, R. N., & Al-Ghamdi, S. (2005). Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus. Annals of Saudi Medicine, 25(4), 283–287. https://doi.org/10.5144/0256-4947.2005.283

Amirhakimi, A., Karamifar, H., Moravej, H., & Amirhakimi, G. (2011). Serum resistin level in obese male children. Journal of Obesity, 2011, 953410. https://doi.org/10.1155/2011/953410

Brosolo, G., Da Porto, A., Bulfone, L., Vacca, A., Bertin, N., Scandolin, L., Catena, C., & Sechi, L. A. (2022). Insulin Resistance and High Blood Pressure: Mechanistic Insight on the Role of the Kidney. Biomedicines, 10(10), 2374. https://doi.org/10.3390/biomedicines10102374

Chigbu, C. (n.d.). Epidemiology of adult obesity in Enugu southeast Nigeria. 135.

Chung, S. T., Katz, L. E. L., Stettler-Davis, N., Shults, J., Sherman, A., Ha, J., Stefanovski, D., Boston, R. C., Rader, D. J., & Magge, S. N. (2022). The Relationship Between Lipoproteins and Insulin Sensitivity in Youth With Obesity and Abnormal Glucose Tolerance. The Journal of Clinical Endocrinology and Metabolism, 107(6), 1541–1551. https://doi.org/10.1210/clinem/dgac113

Clemente-Suárez, V. J., Redondo-Flórez, L., Beltrán-Velasco, A. I., Martín-Rodríguez, A., Martínez-Guardado, I., Navarro-Jiménez, E., Laborde-Cárdenas, C. C., & Tornero-Aguilera, J. F. (2023). The Role of Adipokines in Health and Disease. Biomedicines, 11(5), 1290. https://doi.org/10.3390/biomedicines11051290

Dalton, M., Cameron, A. J., Zimmet, P. Z., Shaw, J. E., Jolley, D., Dunstan, D. W., Welborn, T. A., & AusDiab Steering Committee. (2003). Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. Journal of Internal Medicine, 254(6), 555–563. https://doi.org/10.1111/j.1365-2796.2003.01229.x

Després, J., & Lemieux, I. (2006). Abdominal obesity and metabolic syndrome | Nature. https://www.nature.com/articles/nature05488

Elrayess, M. A., Rizk, N. M., Fadel, A. S., & Kerkadi, A. (2020). Prevalence and Predictors of Insulin Resistance in Non-Obese Healthy Young Females in Qatar. International Journal of Environmental Research and Public Health, 17(14), 5088. https://doi.org/10.3390/ijerph17145088

Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009). Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proceedings of the National Academy of Sciences of the United States of America, 106(36), 15430–15435. https://doi.org/10.1073/pnas.0904944106

Finn, A. V., Nakano, M., Narula, J., Kolodgie, F. D., & Virmani, R. (2010). Concept of vulnerable/unstable plaque. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(7), 1282–1292. https://doi.org/10.1161/ATVBAHA.108.179739

Hocking, S., Samocha-Bonet, D., Milner, K.-L., Greenfield, J. R., & Chisholm, D. J. (2013). Adiposity and Insulin Resistance in Humans: The Role of the Different Tissue and Cellular Lipid Depots. Endocrine Reviews, 34(4), 463–500. https://doi.org/10.1210/er.2012-1041

Jeong, S.-M., Lee, D. H., Rezende, L. F. M., & Giovannucci, E. L. (2023). Different correlation of body mass index with body fatness and obesity-related biomarker according to age, sex and race-ethnicity. Scientific Reports, 13, 3472. https://doi.org/10.1038/s41598-023-30527-w

Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023). Insulin resistance and cardiovascular disease. The Journal of International Medical Research, 51(3), 3000605231164548. https://doi.org/10.1177/03000605231164548

Langsted, A., Madsen, C. M., & Nordestgaard, B. G. (2020). Contribution of remnant cholesterol to cardiovascular risk. Journal of Internal Medicine, 288(1), 116–127. https://doi.org/10.1111/joim.13059

Lee, J. H., Chan, J. L., Yiannakouris, N., Kontogianni, M., Estrada, E., Seip, R., Orlova, C., & Mantzoros, C. S. (2003). Circulating Resistin Levels Are Not Associated with Obesity or Insulin Resistance in Humans and Are Not Regulated by Fasting or Leptin Administration: Cross-Sectional and Interventional Studies in Normal, Insulin-Resistant, and Diabetic Subjects. The Journal of Clinical Endocrinology & Metabolism, 88(10), 4848–4856. https://doi.org/10.1210/jc.2003-030519

Lehr, S., Hartwig, S., & Sell, H. (2012). Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics. Clinical Applications, 6(1–2), 91–101. https://doi.org/10.1002/prca.201100052

Liu, H.-H., & Li, J.-J. (2015). Aging and dyslipidemia: A review of potential mechanisms. Ageing Research Reviews, 19, 43–52. https://doi.org/10.1016/j.arr.2014.12.001

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985). Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412–419. https://doi.org/10.1007/BF00280883

Muniyappa, R., Chen, H., Montagnani, M., Sherman, A., & Quon, M. J. (2020). Endothelial dysfunction due to selective insulin resistance in vascular endothelium: Insights from mechanistic modeling. American Journal of Physiology-Endocrinology and Metabolism, 319(3), E629–E646. https://doi.org/10.1152/ajpendo.00247.2020

Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007). Cardiovascular actions of insulin. Endocrine Reviews, 28(5), 463–491. https://doi.org/10.1210/er.2007-0006

Nordestgaard, B. G., & Varbo, A. (2014). Triglycerides and cardiovascular disease. Lancet (London, England), 384(9943), 626–635. https://doi.org/10.1016/S0140-6736(14)61177-6

Okunogbe, A., Nugent, R., Spencer, G., Ralston, J., & Wilding, J. (2021). Economic impacts of overweight and obesity: Current and future estimates for eight countries. BMJ Global Health, 6(10), e006351. https://doi.org/10.1136/bmjgh-2021-006351

Onyemelukwe, O. U., Ogoina, D., & Onyemelukwe, G. C. (2022). Effect of Obesity on Resistin Concentrations in Normal, Pre-Obese and Obese Apparently Healthy Nigerian-Africans. West African Journal of Medicine, 39(7), 791–702.

Pandey, R. (2018). Resistin, Is There any Role in the Mediation of Obesity, Insulin Resistance and Type-II Diabetes Mellitus? Juniper Online Journal of Case Studies, 6(3). https://doi.org/10.19080/JOJCS.2018.06.555686

Park, H. K., Kwak, M. K., Kim, H. J., & Ahima, R. S. (2017). Linking resistin, inflammation, and cardiometabolic diseases. The Korean Journal of Internal Medicine, 32(2), 239–247. https://doi.org/10.3904/kjim.2016.229

Reilly, M. P., Lehrke, M., Wolfe, M. L., Rohatgi, A., Lazar, M. A., & Rader, D. J. (2005). Resistin is an inflammatory marker of atherosclerosis in humans. Circulation, 111(7), 932–939. https://doi.org/10.1161/01.CIR.0000155620.10387.43

Ross, R., Neeland, I. J., Yamashita, S., Shai, I., Seidell, J., Magni, P., Santos, R. D., Arsenault, B., Cuevas, A., Hu, F. B., Griffin, B. A., Zambon, A., Barter, P., Fruchart, J.-C., Eckel, R. H., Matsuzawa, Y., & Després, J.-P. (2020). Waist circumference as a vital sign in clinical practice: A Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nature Reviews Endocrinology, 16(3), 177–189. https://doi.org/10.1038/s41574-019-0310-7

Russo, B., Menduni, M., Borboni, P., Picconi, F., & Frontoni, S. (2021). Autonomic Nervous System in Obesity and Insulin-Resistance—The Complex Interplay between Leptin and Central Nervous System. International Journal of Molecular Sciences, 22(10), 5187. https://doi.org/10.3390/ijms22105187

Saltiel, A. R., & Kahn, C. R. (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414(6865), 799–806. https://doi.org/10.1038/414799a

Sarafidis, P. A., & Ruilope, L. M. (2006). Insulin resistance, hyperinsulinemia, and renal injury: Mechanisms and implications. American Journal of Nephrology, 26(3), 232–244. https://doi.org/10.1159/000093632

Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001). The hormone resistin links obesity to diabetes. Nature, 409(6818), 307–312. https://doi.org/10.1038/35053000

Su, K., Li, Y., Zhang, D., Yuan, J., Zhang, C., Liu, Y., Song, L., Lin, Q., Li, M., & Dong, J. (2019). Relation of Circulating Resistin to Insulin Resistance in Type 2 Diabetes and Obesity: A Systematic Review and Meta-Analysis. Frontiers in Physiology, 10, 1399. https://doi.org/10.3389/fphys.2019.01399

Vega, G. L., Adams-Huet, B., Peshock, R., Willett, D., Shah, B., & Grundy, S. M. (2006). Influence of body fat content and distribution on variation in metabolic risk. The Journal of Clinical Endocrinology and Metabolism, 91(11), 4459–4466. https://doi.org/10.1210/jc.2006-0814

Vekic, J., Zeljkovic, A., Stefanovic, A., Jelic-Ivanovic, Z., & Spasojevic-Kalimanovska, V. (2019). Obesity and dyslipidemia. Metabolism, 92, 71–81. https://doi.org/10.1016/j.metabol.2018.11.005

Volpe, M., & Gallo, G. (2023). Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC). Frontiers in Cardiovascular Medicine, 10, 1136340. https://doi.org/10.3389/fcvm.2023.1136340

Wanjau, M. N., Kivuti-Bitok, L. W., Aminde, L. N., & Veerman, J. L. (2023). The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: A stakeholder engaged modelling study. Cost Effectiveness and Resource Allocation, 21(1), 69. https://doi.org/10.1186/s12962-023-00467-3

Wondmkun, Y. T. (2020). Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 3611–3616. https://doi.org/10.2147/DMSO.S275898

Woolcott, O. O., & Seuring, T. (2022). Prevalence trends in obesity defined by the Relative Fat Mass (RFM) index among adults in the United States: 1999−2018: Abstracts from the 19h Annual World Congress on Insulin Resistance Diabetes & Cardiovascular Disease. Metabolism: Clinical and Experimental, 128. https://doi.org/10.1016/j.metabol.2021.155027

Yamauchi, T., & Kadowaki, T. (2013). Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metabolism, 17(2), 185–196. https://doi.org/10.1016/j.cmet.2013.01.001

Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005). Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 436(7049), 356–362. https://doi.org/10.1038/nature03711

Yashi, K., & Daley, S. F. (2024). Obesity and Type 2 Diabetes. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK592412/

Downloads

Published

2025-01-14

Issue

Section

Full Length Research Articles

How to Cite

Relationship between Serum Resistin and Insulin Resistance among Obese Non-Diabetic Patients in a Nigerian Tertiary Hospital. (2025). Nigerian Journal of Physiological Sciences, 39(1), 23-29. https://doi.org/10.54548/njps.v39i1.4

Similar Articles

1-10 of 48

You may also start an advanced similarity search for this article.